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Abstract: The influence of tethering silicon microelec-
trode arrays on the cortical brain tissue reaction was com-
pared with that of untethered implants placed in the same
location by identical means using immunoflourescent
methods and cell type specific markers over indwelling
periods of 1–4 weeks. Compared with untethered, freely
floating implants, tethered microelectrodes elicited signifi-
cantly greater reactivity to antibodies against ED1 and
GFAP over time. Regardless of implantation method or in-
dwelling time, retrieved microelectrodes contained a layer
of attached macrophages identified by positive immunor-
eactivity against ED1. In the tethered condition and in
cases where the tissue surrounding untethered implants
had the highest levels of ED1þ and GFAPþ immunoreac-
tivity, the neuronal markers for neurofilament 160 and
NeuN were reduced. Although the precise mechanisms
are unclear, the present study indicates that simply tether-
ing silicon microelectrode arrays to the skull increases the
cortical brain tissue response in the recording zone imme-
diately surrounding the microelectrode array, which sig-
nals the importance of identifying this important variable
when evaluating the tissue response of different device
designs, and suggests that untethered or wireless devices
may elicit less of a foreign body response.  2007 Wiley
Periodicals, Inc. J Biomed Mater Res 82A: 169–178, 2007
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INTRODUCTION
Implanted electrodes are routinely employed in
various research applications for recording and stim-
ulating nervous tissue. High density, multisite elec-
trode arrays represent a promising area of biomedi-
cal device development.1 Already, multisite stimulat-
ing electrodes are being used for the treatment of
deafness2 as well as to alleviate symptoms of Parkin-
son’s disease.3,4 In addition, advances in our under-
standing of the functional architecture of the central
nervous system (CNS) have been facilitated by the
availability of multisite recording electrodes.5
The emergence of micromachining technology has
yielded increasingly smaller and more sophisticated
electrodes capable of recording from greater volumes
of neural tissue with improved spatial resolution.6,7
Despite substantial technological advances in hard-
ware and design, many devices perform inconsis-
tently in chronic applications.8
Available evidence suggests that the brain tissue
reaction is responsible for the degradation of record-
ing performance. Studies conducted over three dec-
ades have demonstrated that encapsulation tissue
eventually surrounds implanted electrodes, as occurs
with other types of materials implanted in the nerv-
ous system, which contains a variety of cell types
and their secreted matrix including meningeal fibro-
blasts, macrophages, and reactive astrocytes that
appear to vary both in spatial distribution and in
abundance over time.9–16 Current theories regarding
the mechanism of recording instability and degrada-
tion suggest that encapsulation of the electrode by
reactive astrocytes acts to electrically insulate the
electrode from nearby neurons,8,9,15,16 possibly hin-
dering diffusion17 and/or increasing the distance
between the electrode and adjacent neurons.8
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While much attention has been placed on charac-
terizing the astrocytotic response to microelectrode
implantation, less attention has focused on the fate
of nearby neurons. A recent report observed that
neuronal loss accompanies the foreign body re-
sponse to chronically implanted silicon microelec-
trode arrays, which appears to be separate from the
cell loss that is caused by the initial implantation
trauma.18 The investigators observed persistent ED1
immunoreactivity in the tissue surrounding silicon
microelectrode arrays implanted in rat brain tissue,
which was accompanied by a reduction in nerve
fiber density and loss of nerve cell bodies. Persistent
upregulation of ED1 and neuronal cell loss was not
observed in microelectrode stab wound used as con-
trols, suggesting that the foreign body response
plays an important role in the loss of neurons. In ad-
dition, explanted electrodes were covered with ED1/
MAC1 positive cells that released both pro-inflam-
matory and neurotoxic molecules in vitro, which
prompted the authors to speculate that inflamma-
tion-associated neurotoxicity may be another factor
contributing to the loss of recording performance.
While the literature reflects a concerted effort to
identify and characterize the changing characteristics
of the foreign body response around various types
of implanted electrodes, most studies have focused
on fully functional implants or on passive, nonfunc-
tional implants using a variety of anchoring meth-
ods. At present, it is unclear whether the manner in
which an electrode is anchored has an impact on the
foreign body response. To address this issue, the
current study was designed to study the influence of
electrode tethering mechanism on the adjacent brain
tissue reaction over time by comparing different
models of anchoring the same planar silicon micro-
electrode array in rat cortex, a target tissue for neural
prosthetic development.19 Our results indicate that
the method of anchoring an electrode in brain tissue
(tethering) significantly affects the brain tissue re-
sponse and suggests that freely floating (wireless)
electrodes may elicit less brain tissue reactivity than
present designs that require the passage of electrically
conductive materials through an opening in the skull
to interact with electrical devices outside the body.
MATERIALS AND METHODS
Microelectrodes
Silicon microelectrodes fabricated for chronic implanta-
tion were supplied by the Center for Neural Communica-
tion Technology (CNCT) at the University of Michigan
(http://www.engin.umich.edu/facility/cnct/). All elec-
trodes contained a single shank with the following dimen-
sions: length, 5 mm; width, 200 mm at the base tapering to
33 mm at the tip; thickness, 15 mm along the shank and
2 mm at the tip. All electrodes were cleaned by immersion
in 70% ethanol, followed by rinsing in sterile, deionized
water, and sterilized prior to implantation by ethylene oxide.
Animal surgery
All procedures involving animals were conducted using
sterile technique in accordance with protocols approved by
the University of Utah Institutional Animal Care and Use
Committee and NIH guidelines for the care and use of lab-
oratory animals. Adult male Fischer 344 rats (225–250 g)
were anesthetized with a cocktail of ketamine (65 mg/kg),
xylazine (7.5 mg/kg), and acepromazine (0.5 mg/kg).
Upon reaching full depth of anesthesia, the eyes were cov-
ered with ophthalmic ointment and the head was shaved.
The scalp was disinfected by treatment with isopropanol,
followed by liberal treatment with butadiene. Animals were
transferred to a stereotaxic frame (Stoelting, Wood Dale, IL)
set under a stereomicroscope. A midline incision extending
the length of the skull was made. For all implant types, a
3-mm-diameter burr hole was created through the skull
with a trephine drill bit held and lowered under stereotac-
tic control and driven pneumatically. The center of the
hole was positioned at coordinates þ0.2 mm forward of
bregma and 3 mm lateral to bregma. While drilling, sterile
PBS was applied to the bit with a 10-cm3 syringe through
a 25G needle to cool the drill site and reduce heat transfer
to the underlying cortical tissue. The bone plug was
removed with fine forceps under stereomagnification. The
hole was rinsed liberally with sterile PBS to remove drill
debris and the dura was carefully opened with a 21G nee-
dle. The various implant methods employed are described
later and shown in Figure 1.
Untethered microelectrodes
Untethered microelectrodes were held with a pair of
fine forceps and lowered into the brain by hand to a depth
of 2 mm. The top of the microelectrode was severed with
scissors so that the entire electrode shaft was implanted in
brain tissue leaving the top of the electrode flush with the
surface of the cortex. The bone plug was replaced, and the
scalp sutured with 5/0 silk sutures (Fig. 1).
Conventionally tethered microelectrodes
Another group of microelectrodes was implanted using
a conventional method as employed in chronic recording
experiments, two bone screws were attached to the skull
*4–5 mm on either side of the sagital suture in the tempo-
ral bone. A single microelectrode with attached connector
was carefully lowered into the brain at coordinates using a
modified stereotactic micromanipulator. The electrode was
secured with silicone elastomer (Kwik-cast; World Preci-
sion Instruments, Sarasota, FL). Acrylic dental adhesive
(Dura Lay; Dental Mfg., Worth, IL) was applied as a slurry
around the bone screws to cover the skull, and the connec-
tor was lowered into position on the acrylic cement. Addi-
170 BIRAN, MARTIN, AND TRESCO
Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
tional acrylic was applied with a 1-cm3 syringe to sur-
round and secure the connector to the screws and also to
capture the connection to the microelectrode array (Fig. 1).
The scalp was left to heal around the fixture.
Euthanasia and tissue processing
At various time points after implantation, animals were
euthanized with a mixture of ketamine (70 mg/kg) and
xylazine (30 mg/kg). Animals were perfused transcardially
at a flow rate of 50 mL/min with a minimum of 125 mL of
ice-cold PBS, followed by 125 mL of fresh ice-cold 4% (w/v)
paraformaldehyde. Following perfusion, each brain was
carefully removed from the skull. Brains were postfixed
overnight in 4% paraformaldehyde in PBS. Microelectrodes
were carefully retrieved with sharp microdissection for-
ceps and processed for immunostaining.
Histology and immunostaining
Brains were cut in horizontal sections of 40 mm thickness
with a Vibratome (Vibratome, St. Louis, MO). A list of
antibodies used, their source, and dilution is detailed in
Table I. All antibodies were diluted in blocking solution
consisting of 4% (v/v) normal goat serum, 0.3% (v/v) Tri-
ton-X-100, and 0.1% (w/v) sodium azide. Approximately
6–8 tissue sections at the level of the cerebral cortex per
animal were immunostained for each marker. The sections
for each staining set spanned *1.8 mm of the cerebral cor-
tex, with each section separated from the next by about
300 mm distance. Sections were incubated for 1 h with
blocking solution at room temperature. Primary antisera
were applied overnight at 48C. After three rinses in PBS
(15 min/rinse), appropriately matched secondary antibod-
ies were applied for 1 h at room temperature. ED1 and
MAC-1 (OX-42) stains were amplified by applying a bio-
tinylated secondary antibody, followed by incubation with
fluorescently labeled streptavidin for 1 h. Alexa-488 and
Alexa-594 labeled secondary antibodies and streptavidin
were purchased from Molecular Probes (Eugene, OR). Bio-
tinylated secondary antibodies were purchased from
Southern Biotech (Birmingham, AL). Secondary antibodies
were diluted in blocking solution as follows: Alexa-488/
594 secondaries, 10 mg/mL; biotinylated secondaries, 5 mg/mL;
Alexa-488–streptavidin, 2.5 mg/mL. After washing with
PBS, sections were counterstained with 10 mM DAPI
(Molecular Probes) mounted onto microscope slides using
Fluoromount-G (Southern Biotech) and covered with a
coverglass. Retrieved electrodes were treated in a similar
manner.
Imaging and quantification
For quantification of the spatial distribution of antigens,
digital images were collected using a Coolsnap color CCD
Figure 1. Diagram of different implantations schemes.
(A) Microelectrodes were lowered into the cerebral cortex
at the indicated stereotaxic coordinates. (B,C) Diagrams
indicating the implantation method and materials used for
(B) untethered silicon microelectrode arrays and (C) con-
ventionally tethered silicon microelectrode arrays.
TABLE I
Summary of Antibodies
Antibody Antigen Cell Type(s) Isotype
Concentration
(mg/mL) Vendor
CD68 (ED1) Lysosomal glycoprotein Microglia, macrophages Mouse IgG1 1.0 Serotec
CD11b/c (OX-42) CR3 complement receptor Microglia, macrophages Mouse IgG2a 2.5 Pharmingen





Mouse IgG1 6.0 Sigma
Neurofilament-160 Medium neurofilament
polypeptide
Neurons Mouse IgG1 2.4 Sigma
NeuN Neuronal nuclei Neurons Mouse IgG1 5.0 Chemicon
BRAIN TISSUE RESPONSE TO TETHERED SILICON MICROELECTRODE ARRAYS 171
Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
(Roper Scientific, Trenton, NJ) attached to a Nikon E600
microscope using Image Pro 4.5 software (Media Cybernet-
ics, Silver spring, MD), using the method as previously
described in Ref. 18.
Animal numbers and statistical analysis
A total of 44 adult male Fischer 344 rats (225–250 g)
were used as described in Table II. The reactive distance for
GFAP was established arbitrarily as the average distance
where the relative intensity of immunoreactivity was three
times the background. To assess differences in immunoreac-
tivity between conditions, comparisons of mean intensity
values at discrete distances were compared by a two-tailed
Students t test with significance set at p < 0.05.
RESULTS
All animals survived implantation with no compli-
cations.
Comparison of conventionally tethered
and untethered microelectrodes
In order to assess the extent of inflammation
between untethered and conventionally tethered mi-
croelectrodes, we examined the presence of macro-
phages using indirect immunofluorescence for ED1,
a glycoprotein enriched in the lysosomal membranes
of phagocytically active macrophages and micro-
glia.20 Immunopositive cells, predominantly ameboid
in morphology, were observed adjacent to the im-
plantation site and observed throughout nearby tis-
sue of both types of implants. ED1þ cells containing
short processes were also observed hundreds of
micrometers away from the implantation tract, as
has been described by others,16 and often times were
associated with vasculature, suggesting extravasation
was ongoing throughout this period. In some speci-
mens, ED1 immunoreactivity was observed within
the implant cavity, which presumably resulted from
cells being scraped off the surface of the electrode
upon retrieval. Autofluorescent hemosiderin deposits
were also observed within and immediately near
some but not all implant cavities at the 7-day time
point. The deposits appeared dark under light mi-
croscopy and contained no definable DAPI-stained
nuclei under fluorescence. There was substantial var-
iability in the amount of hemosiderin at implant
sites of different animals with no apparent connec-
tion to the implant anchoring method, presumably
resulting from variable vascular damage induced by
implantation trauma.
At all time points, conventionally tethered micro-
electrode sites contained a significantly greater abun-
dance and relative intensity of ED1 immunoreac-
tivity compared with untethered, freely floating
implants (Fig. 2). ED1 reactivity around the implan-
tation site was readily notable at 1 and 2 weeks, of-
ten extending over an area as much as half a milli-
meter in diameter. The average distance around con-
ventionally tethered electrodes was greater at each
time point by approximately threefold at 1 week, and
10-fold greater at 2 and 4 weeks, respectively (Fig. 2,
bottom panel). By 4 weeks, the reaction around
untethered electrodes had subsided to only a thin
band of ED1þ cells surrounding the implant (Fig. 2).
The extent of ED1 immunoreactivity around both
implant types diminished over time (Fig. 2). By
4 weeks the average distance of ED1 immunoreac-
tivity around conventionally tethered microelectrodes
had dropped to approximately half of its initial
value. In neither condition did ED1 immunoreactiv-
ity return to a normal unreactive state, that is, one
with no observable ED1þ immunoreactivity. Thus,
ED1 immunoreactivity was greater in the conven-
tionally tethered group compared with the same bio-
material implanted without a tethering mechanism.
While the extent of macrophage activation decreased
over time and occupied a smaller zone surrounding
the microelectrodes, ED1þ immunoreactivity never
disappeared around either type of microelectrode.
Conventionally tethered microelectrodes produce
greater GFAP immunoreactivity than untetherd,
freely floating microelectrode arrays
Analysis of the GFAP immunoreactivity over time
showed that hypertrophied intensely labeled astro-
cytes, like those observed around cortical stab
wounds,21 surrounded both conventionally tethered
and untethered implants (Fig. 3), often forming a
dense band at a distance removed from the implant
interface. At every time point, the extent of GFAP
immunoreactivity was significantly greater around
conventionally tethered electrodes compared to the
untethered cohort. For both types of implants, the re-
active band of astrocytes was never observed
directly opposing the implant interface, but resided
outside the ED1þ immunolabeled zone. After week
2, there appeared to be little change in the extent of
GFAP labeling observed around untethered micro-
electrodes that rarely formed a dense tight capsule.
However, in the tethered cohort while the extent of
the response significantly declined it often collapsed
TABLE II
Animal Numbers in Each Category
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Figure 2. Comparison of the ED1þ spatial and temporal reac-
tivity surrounding untethered and conventionally tethered sili-
con microelectrode arrays. Representative images of horizontal
sections perpendicular to the implantation tract in the cortex of
young adult rats receiving untethered (A,C,E) or conventionally
tethered (B,D,F) microelectrode arrays at 1 week (A,B), 2 weeks
(C,D), and 4 weeks (E,F) after implantation, illustrating an ele-
vated ED1 immunoreactivity in brain tissue surrounding the im-
planted microelectrode arrays. The tissue sections shown were
from the mid cerebral cortex. Scale bar ¼ 100 mm. Lower panel
summarizes the quantitative comparison of spatial and temporal
distribution of elevated ED1.Asterisk indicates significant differ-
ences at a pvalue<0.05. [Color figure can beviewed in the online
issue,which is available atwww.interscience.wiley.com.]
Figure 3. Comparison of elevated GFAP immunoreactiv-
ity as a function of distance surrounding the electrode
over time. Representative images of horizontal tissue sec-
tions perpendicular to the electrode tract of untethered
(A,C,E) or conventionally tethered (B,D,F) microelectrodes
at 1 week (A,B), 2 weeks (C,D), and 4 weeks (E,F) after im-
plantation, illustrating elevated reactivity around conven-
tionally tethered microelectrodes relative to freely floating
microelectrodes. Tissue sections were analyzed at the level
of the cerebral cortex. Scale bar ¼ 100 mm. Lower panel
summarizes the quantitative comparison of spatial and
temporal distribution of elevated GFAP. Asterisk indicates
significant differences at a p value <0.05.
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into a more compact zone as observed by others.16
As was observed for ED1, elevated GFAP reactivity
persisted around the sites of both implant types over
the course of the study.
Retrieved microelectrodes are covered
with macrophages
Under light microscopy retrieved electrodes con-
tained adherent material of cellular origin. In order
to determine the identity of the attached cells, micro-
electrodes were immunostained with the same bat-
tery of antisera applied to tissue sections. Staining
with DAPI revealed that all retrieved microelec-
trodes contained on both sides of the implant small
cells with compact nuclei. The extent of electrode
surface area covered by the cells varied between dif-
ferent electrodes, regardless of electrode type or the
duration of the indwelling period. The adherent cells
were almost entirely immunopositive for ED1 and
MAC-1 (OX-42), indicating that they were activated
microglia and hematogenous macrophages (Fig. 4).
The adherent cell layers were similar in appearance
to the cells observed immediately adjacent to the
implant cavity in tissue sections. None of the elec-
trodes contained neurofilamentþ material and only
rarely was GFAPþ material detected. Where GFAP
was observed, it was often in fragments that re-
sembled astrocytic processes. No complete GFAPþ
cells were observed. Furthermore, the GFAP-reactive
material was never in direct contact with the elec-
trode surface, rather it was attached to the surface of
the macrophage/microglial cell layer.
Reduced neuron density around microelectrodes
The impact of electrode implantation on the sur-
rounding neuronal population was assessed by im-
munostaining for neurofilament 160, which in our
hands stains rat brain cortical neuron dendrites,
somas and axons, and NeuN, a nuclear antigen
found only in neuronal cells. In the tethered cohort,
tissue surrounding the electrode contained a reduced
expression of neurofilamentþ immunostaining and
staining for NeuN (Fig. 5). In the untethered cohort,
little loss of neurofilament 160 was observed espe-
cially at 4 weeks [Fig. 5(A)]. However, around teth-
ered implants decreased neurofilament 160 was
strikingly evident [Fig. 5(B)]. The extent of reduction
varied with the dorsal/ventral aspect of the implant.
In tethered implants, we observed reductions in
neurofilament reactivity extending as far away as
250 mm, but on average the reduction was in a zone
of 100 mm around the implant site as previously
described (Fig. 5, bottom panel).18
The distance between the electrode interface and
the nearest NeuNþ cell body appeared correlated to
Figure 4. Cell coated retrieved planar silicon microelec-
trode arrays. (A–C) Representative images of microelectrode
arrays staining positive with antibodies directed against
ED1, an antigen expressed predominantly on lysosomal
membranes of macrophages, but not found in normal brain
tissue at 4 (A), 10 (B), and 20 (C). The nuclei of cells is
shown stained blue with DAPI. Scale bar ¼ 100 mm. [Color
figure can be viewed in the online issue, which is available
at www.interscience.wiley.com.]
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Figure 5. Representative horizontal images showing neurofilament and neuronal cell bodies distribution around implan-
tation tracts at mid cortical level at 4 weeks after implantation. A comparison of neurofilament 160 immunostaining
between untethered (A) and tethered microelectrodes (B). Immunostaining with the NeuN antibody demonstrates reduced
neuronal bodies around tethered microelectrodes (D) compared with untethered controls (C). The inset in (E) shows the
area around the implantation tract shown in (D) double-stained for ED1 showing the presence of macrophages. Reduction
in neuronal cell body density correlated with a high degree of inflammation and was minimal in the untethered group.
Scale bar ¼ 100 mm, and asterisks (*) mark the location of the microelectrode tract. Lower panel provides a comparison of
the average cohort neurofilament reactivity profile as a function of distance from the electrode after 4 weeks after showing
minimal reduction in the untethered group and a greater reduction in the tethered cohort as previously reported.18
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the severity of the macrophage reaction. Near un-
tethered implants where the spatial extent of ED1
immunoreactivity was low, NeuNþ neuronal bodies
were found adjacent to the microelectrode brain tis-
sue interface [Fig. 5(C)]. In contrast, NeuNþ neuro-
nal cell bodies were much farther away from teth-
ered microelectrodes that exhibited a larger ED1
response [Fig. 5(D,E)].
DISCUSSION
The current study demonstrates that the method
of anchoring silicon micromachined electrode arrays
to the skull significantly influences the brain tissue
reaction, including greater macrophage/microglial
activation, increased astrogliosis, and a decrease in
immunoreactivity against neurofilament and NeuN
at the device brain tissue interface. Increased reactiv-
ity around tethered microelectrodes may result from
a number of variables including the differing surgi-
cal procedure, tethering forces, and the provision of
a pathway for meningeal cell migration. Similarities
in the spatial and temporal characteristics of the
response were in agreement with previous re-
ports.15,16 Regardless of microelectrode anchoring tech-
nique, a response involving macrophages persisted at
the electrode interface over the course of the study
and retrieved microelectrodes contained to varying
degrees adherent macrophages on the device surface.
An interesting finding was the reduction in neuro-
nal density as well as the decrease in neuronal
bodies at the electrode brain tissue interface, which
was greatest in the tissue immediately surrounding
highly reactive implant sites. In some tethered speci-
mens, this reduction extended beyond the ‘‘kill
zone’’ previously reported using another electrode
implantation paradigm.12 In the current study, re-
duced nerve fiber and soma density coincided with
relatively higher levels of ED1 immunoreactivity, an
indicator of inflammation. The reduction in neuronal
density was variable between animals within a
group and variable along the dorsal ventral axis of a
given implant, perhaps related to differences in local
neuroanatomy, micromotion, or tethering forces.
It is possible especially at the early time points
that we were observing degenerating axons that
were mechanically severed during implantation.
Indeed, the appearance of swollen neuronal fibers
around many electrode sites resembled the retraction
bulbs characteristic of severed axons described as
early as 1959 by Ramon and Cajal.22 Furthermore,
our observations are also consistent with the fact
that activated microglia accumulate at sites of nerve
fiber degeneration after axotomy.23 However, the
larger reduction in neuronal density around tethered
microelectrodes is unlikely to be due to implant-
induced axotomy alone, as no such observations
were made around untethered microelectrodes and
stab wound controls.18 The extent to which the pres-
ence of macrophage and elevated microglial activa-
tion contributed to neuronal damage is unclear.
Nevertheless, the functional implications of these ob-
servations on recording performance may be very
important. It appears that in certain instances, neuro-
nal death and degeneration take place over distances
that span the effective recording range of this type
of microelectrode.6 The variability of our observa-
tions may explain, in part, the inconsistent nature of
long-term recordings using different hardware con-
figurations and implantation schemes.
Using a different CNS implantation paradigm,
Kim et al.24 described increased microglial and astro-
cyte reactivity around larger tubular implants. While
the size of the implants was substantially larger than
the microelectrodes employed in the current study, a
similar pattern of reactivity was observed. Several
important differences between the Kim et al. study
and the present study deserve mention. For example,
the silicon microelectrode arrays used in the present
study have an elastic modulus that is several orders
of magnitude stiffer than the thermoplastic employed
in the Kim et al. study. The surface architecture was
also significantly different. In the present study, the
silicon surface was relatively flat on the nanometer
level while the hollow fiber used in the Kim et al.
study possessed macroscopic holes and presented
orders of magnitude larger surface area. Addition-
ally, the footprint or overall size of the device in the
Kim et al. study was an order of magnitude larger
than the implants studied here. Even with all of
these differences, the general appearance of the for-
eign body response was similar. In both cases the
elevation of ED1 was restricted to the biotic–abiotic
interface and the elevation of GFAP extended only
several hundred micrometers, suggesting that the
extent of tissue reactivity does not necessarily scale
with the size of the device but rather appears to be a
product of the interface. Clearly this requires further
study under better controlled conditions. Taken to-
gether, these observations suggest a reproducible
influence of anchorage on the tissue response adja-
cent to devices implanted in the CNS and suggests
that the reaction is independent of the specific im-
plant material or its dimensions.
While the precise mechanisms responsible for the
increased tissue reactivity to tethered implants are
unknown, several explanations appear reasonable
including: (1) shearing and/or compression of adja-
cent tissue due to the stiffness mismatch of silicon
implants and brain tissue caused by relative motion
between the skull and the brain itself, and (2) the
potential migration and colonization of the elec-
trode interface by fibroblasts from the overlying
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meninges.24 We have frequently observed histopatho-
logical evidence suggesting movement of tethered
electrodes within cortical tissue, characterized by
narrow and elongated cavities that are much larger
than the corresponding cross section of the microelec-
trode. Such movement would clearly result in a wider
zone of inflammation and tissue reactivity. If such
mechanisms are at play, it follows that it may be possi-
ble to improve microelectrode biocompatibility by
addressing the issue of implant movement and fibro-
blast infiltration through modifications of the electrode
surface, changes in the tethering approach, or to devise
microelectrode implantation strategies which avoid
cranial tethering altogether. It is also possible that the
irregularly shaped reactions are caused by asymmetric
degeneration of dendrites or axonal projections that
occur along the implantation tract. Clearly more
detailed studies are required to shed light on the pre-
cise mechanisms responsible for these observations.
In general, the major difference in tissue reactivity
between tethered microelectrodes and untethered
microelectrodes was in magnitude rather than the
composition and arrangement of the tissue adjacent
to the implant. Around all microelectrodes we ob-
served a stratified cellular response composed of an
activated zone of microglia attached to and residing
most proximal to the microelectrode shaft and a
layer of hypertrophied intensely GFAPþ reactive
astrocytes surrounding the macrophages, and finally,
a somewhat normal parenchyma that included a
normal arrangement of neuronal bodies. Within the
zone of reactivity we observed a reduction of neuro-
nal processes and nerve cell bodies.
There is no evidence from our study, and from
later time points in other studies examining the
brain tissue reaction to implanted silicon microelec-
trodes,16,19 that the macrophage phenotype (ED1þ)
disappears from the electrode–brain tissue interface.
The persistence of this phenotype at the interface
contrasts with the relatively rapid disappearance of
activated microglia and macrophages near cortical
stab wounds as previously reported25 and as ob-
served following microelectrode stab wounds made
by electrodes.18 Aside from supporting the widely
acknowledged phenomenon that nondegrading im-
plants elicit a chronic foreign body reaction, the ob-
servation of a persistently activated macrophage
response at electrode–brain tissue interface raises the
question of whether such a response can have long-
term functional implications for recording perform-
ance of neuroprosthetic devices.
Growing evidence suggests that persistently acti-
vated microglia, such as those found around in-
soluble plaques in Alzheimer’s disease,26 may be a
source of local neurotoxicity. In the CNS, like in the
periphery, it is has been observed that the inability
of macrophages to clear insoluble material results in
a phenomenon described as ‘‘frustrated phagocyto-
sis’’ which is characterized by increased secretion of
inflammatory products that may directly or indi-
rectly cause neuronal death or substantially alter
synaptic activity.27 Often these secreted products
also perpetuate microglial activation through auto-
crine stimulation and by further promoting adjacent
cell death. Microglial-induced neuronal death can be
mediated by a myriad of secreted compounds. The
most notable includes various complement compo-
nents that can cause neuronal lysis,28–30 such as cyto-
kines TNFa and IL-1b, which have direct and indi-
rect mechanisms of action,27 prostaglandins that
indirectly contribute to excitotoxic neuronal death,31
as well as superoxide anion32 and elevated nitric ox-
ide.33,34 TNFa, perhaps the archetypal pro-inflamma-
tory cytokine, is secreted at high levels by activated
microglia.35,36 It has been shown that TNFa, in the
presence of activated microglia, mediates excitotoxic
neuronal death by causing extensive release of gluta-
mate from adjacent astrocyte,37 and has recently
been shown to be released by the cells attached to
retrieved silicon microelectrode arrays.18 Even with-
out causing neuronal death, elevated but sublethal
doses of this and other microglial-derived agents can
alter neuronal activity27,37 and thereby reduce the
flow of electrical activity within the cortical column.
In light of or our own observations, it is tempting,
therefore, to hypothesize that such events may also
take place around all chronically indwelling im-
plants regardless of material composition. Whether
in fact there exists a consistent pattern of neuronal
death surrounding chronically implanted devices
remains uncertain and will require further investiga-
tion. It is also possible, by the very probability that
one electrode tract may cause more or less tissue
trauma than another (for example, by variation in
the degree of vascular trauma or variations in local
neuroanatomy), that the degree of neuronal damage
is naturally a highly variable outcome and may in
part explain the variable nature of achieving success-
ful chronic single unit recording.
CONCLUSIONS
The current study demonstrates that the manner
that a recording device in anchored to the skull
alone can increase the brain reaction to implanted
microelectrode arrays. The increased reactivity sur-
rounding conventionally tethered microelectrodes
may be due, in part, to variables other than the bio-
materials alone and includes the presence of acrylic
resin and bone screws used to fix the electrode, as
well as the anchoring mechanisms and tethering
forces involved. Our study also suggests that the per-
sistence of macrophages surrounding chronically im-
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planted neuroprosthetic devices may have deleterious
effects on adjacent nerve cell bodies and their proc-
esses, and therefore represents another potentially im-
portant mechanism that may be responsible for de-
creased performance and reliability of this emerging
class of biomedical technology and represent a thera-
peutic target for enhancing their biocompatibility.
The authors gratefully acknowledge Ms. Lindsay Alder,
Ms. Mindy Naegle, and Dr. Elena Budko for their technical
assistance.
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